MDRX Related New Coverage
-
B. Riley Starts Allscripts (MDRX) at Neutral
-
JMP Securities Resumes Allscripts (MDRX) at Market Perform
-
ISI Group Starts Allscripts (MDRX) at Market Weight
-
Wells Fargo Starts Allscripts (MDRX) at Market Perform; Long-term Growth Prospects Muted
-
Lazard Starts ATHN, CERN, QSII, MDAS at Buy, MDRX, OMCL, CPSI, EHTH at Neutral, EPOC at Sell
-
Credit Suisse Starts Allscripts-Misys Healthcare (MDRX) at Outperform
-
Sterne Agee Starts Allscripts-Misys Healthcare (MDRX) at Buy
-
Jefferies Starts Allscripts-Misys Healthcare (MDRX) at Buy
-
Avondale Partners Starts Allscripts-Misys Healthcare (MDRX) at Market Outperform
-
Goldman Sachs Starts Allscripts-Misys Healthcare (MDRX) at Neutral
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
Baird Starts Allscripts-Misys Healthcare (MDRX) at Outperform
-
Oppenheimer Starts MDRX, MDAS, CPSI at Outperform, QSII, AH, EM at Perform, ATHN, CERN at Underperform
-
FBR Capital Starts Allscripts-Misys Healthcare (MDRX) at Market Perform; Merged Healthcare IT Co. Has Strong Base, But Plenty of Work to Do
-
Morgan Stanley Starts Cerner (CERN), Quality Systems (QSII) at Overweight, Allscripts (MDRX), MedAssets (MDAS) at Equalweight
-
Citi Starts Allscripts-Misys Healthcare (MDRX) at Buy
-
Barclays Reinstates an 'Overweight' Rating on Allscripts Healthcare (MDRX); Just What the Doctor Could Order
-
USB Starts Coverage on Healthcare Information Services Stocks (ATHN & MDRX)
-
Deutsche Bank Reinstates Allscripts (MDRX) with a 'Hold'; ECLP Transaction May Yield Upside, But Valuation & Risks Balanced
-
JP Morgan Resumes Allscripts (MDRX) with a Buy
-
Maxim Group Initiates Coverage on Allscripts-Misys (MDRX) with a Buy
-
Wells Fargo Initiates Coverage on Allscripts-Misys Healthcare (MDRX) with an Outperform
-
Caris & Company Starts Allscripts-Misys (MDRX) at Above Average
-
ThinkEquity Initiates Coverage on Allscripts-Misys Healthcare (MDRX) with an Acuumulate
-
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
-
Brean Murray Initiates Coverage on Allscripts-Misys Healthcare (MDRX)
-
Morgan Keegan Starts Allscripts-Misys (MDRX) at Outperform
-
JMP Starts Allscripts (MDRX) at Market Perform
-
Merrill Lynch Starts Allscrips (MDRX) at Neutral
-
First Analysis Initiates Coverage on Allscripts (MDRX) with an Overweight
-
Raymond James Starts Allscripts (MDRX) at Strong Buy
-
Stifel Nicolaus Initiates Coverage on Allscripts Healthcare (MDRX) with a Buy
-
CIBC Starts Allscripts Healthcare Solutions (MDRX) at Sector Performer
-
Prudential Starts Allscripts Healthcare (MDRX) at Overweight
-
Deutsche Bank Starts Allscripts (MDRX) at Buy
-
BB&T Capital Starts Allscripts Healthcare Solutions (MDRX) at Buy
-
UBS Starts Allscripts (MDRX) at Neutral
-
Thomas Weisel Initiates Coverage Allscripts (Nasdaq: MDRX) with an Outperform
-
Goldman Sachs Starts Allscripts Healthcare (MDRX) at In-Line
-
Lehman Bros. Reinstates Coverage on MDRX with Equalweight
-
Jefferies Initiates MDRX
-
JP Morgan Initiates MDRX
-
JMP Securities Initiates Coverage on a Number of Healtchcare Software Stocks
-
Leerink Swann Started MDRX at Outperform
Back to MDRX Stock Lookup
